Milk Fat Nutrition

Dairy Fats and Related Products

Volumn , Issue , 2009, Pages 28-51

  Parodi, P W ^a  

^a Dairy Australia   (Australia)

Author keywords

Branched chain fatty acids; Conjugated linoleic acid; Conjugated linoleic acids (CLAs) nutrition; Dietary fat and obesity; Fat intake and cancer; Milk fat nutrition; Perceived nutritional negatives in milk; Rumenic acid and type 2 diabetes mellitus; Saturated fatty acids; Sphingolipids in colon cancer prevention

Indexed keywords

DISEASES; LINOLEIC ACID; OILS AND FATS; SATURATED FATTY ACIDS;

COLON CANCER; CONJUGATED LINOLEIC ACID; DIETARY FAT AND OBESITY; MILK FATS; PERCEIVED NUTRITIONAL NEGATIVES IN MILK; TYPE 2 DIABETES MELLITUS;

NUTRITION;

EID: 78650773840     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444316223.ch2     Document Type: Chapter

References (99)

1. Abe, A. & Sugiyama, K. (2005) Growth inhibition and apoptosis induction of human melanoma cells by m-hydroxy fatty acids. Anti-cancer Drugs, 16, 543-549.
2. Aro, A., Mannisto, S., Salminen, I., Ovaskainen, M.-l., Kataja, V. & Uusitupa, M. (2000) Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutrition and Cancer, 38, 151-157.
3. Ballou, L. R., Laulederkind, S. J. F., Rosloniec, E. F. & Raghow, R. (1996) Ceramide signalling and the immune response. Biochimica et Biophysica Acta, 1301, 273-287.
4. Banni, S., Angioni, E., Murru, E., Carta, G., Melis, M. P., Bauman, D., Dong, Y. & Ip, C. (2001) Vaccenic acid feeding increases tissue levels of conjugated linoleic acid and suppresses development of premalignant lesions in rat mammary gland. Nutrition and Cancer, 41, 91-97.
5. Belobrajdic, D. P. & McIntosh, G.H. (2000) Dietary butyrate inhibits NMU-induced mammary cancer in rats. Nutrition and Cancer, 36, 217-223.
6. Belury,M.A. (2002a) Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annual Reviews in Nutrition, 22, 505-531.
7. Belury, M. (2002b) Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. Journal of Nutrition, 132, 2995-2998.
8. Beresford, S.A.A., Johnson, K.C., Ritenbaugh, C., Lasser, N. L., Snetselaar, L.G., Black, H.R., Anderson, G. L., Assaf, A.R., Bassord, T., Bowen, D., Brunner, R. L., Brzyski, R.G., Caan, B., Chlebowski, R. T., Gass, M., Harrigan, R.C., Hays, J., Heber, D., Heiss, G., Hendrix, S. L., Howard, B.V., Hsai, J., Hubbell, F.A., Jackson, R.D., Kotchen, J.M., Kuller, L.H., LaCroix, A. Z., Lane, D. S., Langer, R.D., Lewis, C. E., Manson, J. E., Margolis, K. L., Mossavar-Rahmani, Y., Ockene, J.K., Parker, L.M., Rerri, M.G., Phillips, L., Prentice, R. L., Robbins, J., Rossouw, J. E., Sarto, G. E., Stefanick, M. L., van Horn, L., Vitolins,M. Z.,Wactawski-Wende, J.,Wallace, R.B. & Whitlock, E. (2006) Low-fat dietary pattern and risk of colorectal cancer. JAMA, 295, 643-654.
9. Brownbill, R.A., Petrosian, M. & Llich, J. Z. (2005) Association between dietary linoleic acid and bone mineral density in postmenopausal women. Journal of the American College of Nutrition, 24, 177-181.
10. Chance, D. L., Gerhardt, K.O. & Mawhinney, T. P. (1998) Gas-liquid chromatography-mass spec- trometry of hydroxy fatty acids as their methyl esters tert.-butyldimethylsilyl ethers. Journal of Chromatography A, 793, 91-98.
11. Chen, B.-Q., Xue, Y.-B., Liu, J.-R., Yang, Y.-M., Zheng, Y.-M., Wang, X.-L. & Liu, R.-H. (2003) Inhibition of conjugated linoleic acid on mouse forestomach neoplasia induced by benzo(a)pyrene and chemopreventive mechamisms. World Journal of Gastroenterology, 9, 44-49.
12. Chujo, H., Yamasaki, M., Nou, S., Koyanagi, N., Tachibana, H. & Yamada, K. (2003) Effect of conjugated linoleic acid isomers on growth factor-induced proliferation of human breast cancer cells. Cancer Letters, 202, 81-87.
13. Chung, S., Brown, J.M., Provo, J.N., Hopkins, R. & McIntosh, M.K. (2005) Conjugated linoleic acid promotes human adipocyte insulin resistance through NF-kB-dependent cytokine production. Journal of Biological Chemistry, 280, 38445-38456.
14. Cinque, B., Di Marzio, L., Centi, C., Di Rocco, C., Riccardi, C. & Cifone, M.G. (2003) Sphingolipids and the immune system. Pharmacological Research, 47, 421-437.
15. Corl, B.A., Barbano, D.M., Bauman, D. E. & Ip, C. (2003) cis-9, trans-11 CLA derived endogenously from trans-11 18:1 reduces cancer risk in rats. Journal of Nutrition, 133, 2893-2900.
16. Desroches, S., Chouinard, P.Y., Galibois, I., Corneau, L., Delisle, J., Lamarche, B., Couture, P. & Bergeron, N. (2005) Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the lipid problle and body composition of overweight and obese men. American Journal of Clinical Nutrition, 82, 309-319.
17. Dreon, D.M., Fernstrom, H.A., Campos, H., Blanche, P., Williams, P. T. & Krauss, R.M. (1998) Change in saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. American Journal of Clinical Nutrition, 67, 828-836.
18. Duan, R.-D. (2005) Anticancer compounds and sphingolipid metabolism in the colon. In vivo, 19, 293-300.
19. Duncan, R. E., El-Sohemy, E. & Archer,M. (2004)Mevalonate promotes the growth of tumors derived fromhuman cancer cells in vivo and stimulates proliferation in vitro with enhanced cyclin-dependent kinase-2 activity. Journal of Biological Chemistry, 279, 33079-33084.
20. Eckhardt, E. R.M., Wang, D.Q.-H., Donovan, J.M. & Carey, M.C. (2002) Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers. Gastroenterology, 122, 948-956.
21. El-Sohemy, A. & Archer, M.C. (2000) Inhibition of N-methyl-N-nitrosourea- and 7,12- dimethylbenz[a]anthracene-induced rat mammary tumourigenesis by dietary cholesterol is inde- pendent of Ha- ras mutations. Carcinogenesis, 21, 827-831.
22. Elwood, P.C., Pickering, J. E., Hughes, J., Fehily, A.M. & Ness, A. R. (2004)Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies. European Journal of Clinical Nutrition, 58, 718-724.
23. Fantini, J., Hammache, D., Delezay, O., Yahi, N., Andre-Barres, C., Rico-Lattes, I. & Lattes, A. (1997) Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV1-induced fusion and entry. Journal of Biological Chemistry, 272, 7245-7252.
24. Gurr, M. I. (1998) Milk, nutrition and health. Milk and Health, pp. 9-22, Proceedings of 25th International Dairy Congress, Aarhus.
25. Hanada, K. (2005) Sphingolipids in infectious diseases. Japanese Journal of Infectious Diseases, 58, 131-148.
26. Holick, M. F. (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers and cardiovascular disease. American Journal of Clinical Nutrition, 80, 1678S-1688S. Hooper, L., Summerbell, C.D., Higgins, J. P. T., Thompson, R. L., Clements, G., Capps, N., Davy Smith, G., Riemersma, G. & Ebrahim, S. (2000) Reduced or modified dietary fat for preventing cardiovascular disease (Review). The Cochrane Database of Systematic Reviews, 2, CD002137.
27. Hooper, L., Summerbell, C.D., Higgins, J. P. T., Thompson, R. L., Clements, G., Capps, N., Davy Smith, G., Riemersma, G. & Ebrahim, S. (2000) Reduced or modified dietary fat for preventing cardiovascular disease (Review). The Cochrane Database of Systematic Reviews, 2, CD002137
28. Ip, C., Banni, S., Angioni, E., Carta, G., McGinley, J., Thompson, H. J., Barbano, D. & Bauman, D. E. (1999) Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. Journal of Nutrition, 129, 2135-2142.
29. Ip, C., Chin, S. F., Scimeca, J.A. & Pariza, M.W. (1991) Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Research, 51, 6118-6124.
30. Ip, C., Dong, Y., Ip, M.M., Banni, S., Carta, G., Angioni, E., Murru, E., Spada, S., Melis, M. P. & Saebo, A. (2002) Conjugated linoleic acid isomers and mammary cancer prevention. Nutrition and Cancer, 43, 52-58.
31. Ip,M.M.,Masso-Welch, P.A. & Ip, C. (2003) Prevention of mammary cancer with conjugated linoleic acid: role of stroma and the epithelium. Journal of Mammary Gland Biology and Neoplasia, 8, 103-118.
32. Jackson, S.M. & Demer, L. L. (2000) Peroxisome proliferator-activated receptor activators modulate the osteoblastic maturation of MC3T3-E1 preosteoblasts. FEBS Letters, 471, 119-124.
33. Jensen, R.G. (1995) Handbook of Milk Composition, Academic Press, San Diego.
34. Jensen, R.G. (2002) The composition of bovine milk lipids: January 1995 to December 2000. Journal of Dairy Science, 85, 295-350.
35. Kobayashi, T., Shimizugawa, T., Osakabe, T., Watanabe, S. & Okuyama, H. (1997) A long-term feeding of sphingolipids affected the level of plasma cholesterol and hepatic triacylglycerol but not tissue phospholipids and sphingolipids. Nutrition Research, 17, 111-114.
36. Kritchevsky, D., Tepper, S.A., Wright, S., Czarnecki, S.K., Wilson, T.A. & Nicolosi, R. J. (2004) Conjugated linoleic acid isomer effects in atherosclerosis: growth and regression of lesions. Lipids, 39, 611-616.
37. Kushi, L. & Giovannucci, E. (2002) Dietary fat and cancer. American Journal of Medicine, 113, 63S-70S. Larsson, S.C., Bergkvist, L. & Wolk, A. (2005) High-fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish Mammography Cohort. American Journal of Clinical Nutrition, 82, 894-900.
38. Larsson, S.C., Bergkvist, L. & Wolk, A. (2005) High-fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish Mammography Cohort. American Journal of Clinical Nutrition, 82, 894-900
39. Li, Y. & Watkins, B.A. (1998) Conjugated linoleic acid alters bone fatty acid composition and reduce ex vivo prostaglandin E2 biosynthesis in rats fed n-6 or n-3 fatty acids. Lipids, 33, 417-425.
40. Libby, P., Ridker, P.M. & Maseri, A. (2002) Inflammation and atherosclerosis. Circulation, 105, 1135-1143.
41. Lock, A. L. & Bauman, D. E. (2004) Modifying milk fat composition of dairy cows to enhance fatty acids beneficial to human health. Lipids, 39, 1197-1206.
42. Lock, A. L., Corl, B.A., Barbano, D.M., Bauman, D. E. & Ip, C. (2005a) The anticarcinogenic effect of trans-11 18:1 is dependent on its conversion to cis-9, trans-11 CLA by d9-desaturase in rats. Journal of Nutrition, 134, 2698-2704.
43. Lock, A. L., Horne, C.A.M., Bauman, D. E. & Salter, A.M. (2005b) Butter naturally enriched in conjugated linoleic acid and vaccenic acid alters tissue fatty acids and improves the plasma lipoprotein problle in cholesterol fed hamsters. Journal of Nutrition, 135, 1934-1939.
44. Lock, A. L., Parodi, P.W. & Bauman, D. E. (2005c) The biology of trans fatty acids: implications for human health and the dairy industry. Australian Journal of Dairy Technology, 60, 134-142.
45. Loscher, C. E., Draper, E., Leavy, O., Kelleher, D., Mills, K.H.G. & Roche, H.M. (2005) Conjugated linoleic acid suppresses NF-kB activation and IL-12 production in dendritic cells through ERK- mediated IL-10 induction. Journal of Immunology, 175, 4990-4998.
46. McCann, S. E., Ip, C., Ip, M.M., McGuire, M.K., Muti, P., Edge, S. B., Trevisan, M. & Freudenheim, J. L. (2004) Dietary intake of conjugated linoleic acid and risk of premenopausal and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study). Cancer Epidemiology Biomarkers and Prevention, 13, 1480-1484.
47. McCully, K. S. (1993) Chemical pathology of homocysteine-1. Atherogenesis. Annals of Clinical and Laboratory Science, 23, 447-493.
48. Mitchell, P. L., Langille,M.A., Currie, D. L. &McLeod, R. S. (2005) Effect of conjugated linoleic acid isomers on lipoproteins and atherosclerosis in the Syrian golden hamster. Biochimica et Biophysica Acta, 1734, 269-276.
49. Modrak, D. E., Lew, W., Goldenberg, D.M. & Blumenthal, R. (2000) Sphingomyelin potentates chemotherapy of human cancer xenografts. Biochemical and Biophysical Research Communications, 268, 603-606.
50. Motouri, M., Matsuyama, H., Yamamura, J.-I., Tanaka, M., Aoe, S., Iwanaga, T. & Kawakami, H. (2003) Milk sphingomyelin accelerates enzymatic and morphological maturation of the intestine in artificially reared rats. Journal of Pediatric Gastroenterology and Nutrition, 36, 241-247.
51. Noh, S.K & Koo, S. I. (2004) Milk sphingomyelin is more effective than egg sphingomyelin in inhibiting intestinal absorption of cholesterol and fat in rats. Journal of Nutrition, 134, 2611-2616.
52. Noone, E. J., Roche, H.M., Nugent, A. P. & Gibney,M. J. (2002) The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. British Journal of Nutrition, 88, 243-251.
53. Oliver, M. F. (1997) It is more important to increase the intake of unsaturated fats than to decrease the intake of saturated fats: evidence from clinical trials relating to ischemic heart disease. American Journal of Clinical Nutrition, 66, 980S-986S. Olszewski, A. J. & McCully, K. S. (1991) Homocysteine content of lipoproteins in hypercholes- terolemia. Atherosclerosis, 88, 61-68.
54. Olszewski, A. J. & McCully, K. S. (1991) Homocysteine content of lipoproteins in hypercholes- terolemia. Atherosclerosis, 88, 61-68
55. O'Shea, M., Bassaganya-Riera, J. & Mohede, I.C.M. (2004) Immunomodulatory properties of conjugated linoleic acid. American Journal of Clinical Nutrition, 79, 1199S-1206S. Palmquist, D. L., Lock, A. L., Shingfield, K. J. & Bauman, D. E. (2005) Biosynthesis of conjugated linoleic acid in ruminants and humans. Advances in Food and Nutrition Research, 50, 179-217.
56. Palmquist, D. L., Lock, A. L., Shingfield, K. J. & Bauman, D. E. (2005) Biosynthesis of conjugated linoleic acid in ruminants and humans. Advances in Food and Nutrition Research, 50, 179-217
57. Pariza, M.W. & Hargraves, W.A. (1985) A beef-derived mutagenesis modulator inhibits initiation of mouse epidermal tumours by 7.12-dimethylbenz[a]anthracene. Carcinogenesis, 6, 591-593.
58. Pariza, M.W., Park, Y. & Cook, M. E. (2001) The biologically active isomers of conjugated linoleic acid. Progress in Lipid Research, 40, 283-298.
59. Parodi, P.W. (2002) Health benefits of conjugated linoleic acid. Food Industry Journal, 5, 222-259.
60. Parodi, P.W. (2003) Conjugated linoleic acid in food. Advances in Conjugated Linoleic Acid Research, Volume 2, (eds. J.-L. Sebedio, W.W. Christie & R.O. Adlof), pp. 101-122, AOCS Press, Champaign.
61. Parodi, P.W. (2004) Milk fat in human nutrition. Australian Journal of Dairy Technology, 59, 3-59.
62. Parodi, P.W. (2005) Dairy product consumption and the risk of breast cancer. Journal of the American College of Nutrition, 24, 556S-568S.
63. Parodi, P.W. (2006) Nutritional significance of milk lipids. Advanced Dairy Chemistry,Volume2,3rd edn., (eds. P. F. Fox & P. L.H. McSweeney), pp. 601-639, Springer, New York
64. Patton, S. (2004) Milk, Transaction Publishers, New Brunswick.
65. Peterlik, M. & Cross, H. S. (2005) Vitamin D and calcium dedicits predisposes for multiple chronic diseases. European Journal of Clinical Investigation, 35, 290-304.
66. Pirozzo, S., Summerbell, C., Cameron, C. & Glasziou, P. (2002) Advice on low-fat diets for obesity (Review). The Cochrane Database of Systematic Reviews, 2, CD003640.
67. Polikandriotis, J.A., Mazzella, L. J., Rupnow, H. L. & Hart, C.M. (2005) Peroxisome proliferator- activated receptor γ ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor γ -dependentmechanisms. Atherosclerosis, Thrombosis and Vascular Biology, 25, 1810-1816.
68. Prentice, R. L., Caan, B., Chleboski, R. T., Patterson, R., Kuller, L.H., Ockene, J.K., Margolis, K. L., Limacher, M.C., Manson, J. E., Parker, L.M., Paskett, E., Phillips, L., Robbins, J., Rossouw, J. E., Sarto,G. E., Shikany,M., Stefanick,M. L.,Thomson,C.A., vanHorn,L.,Vitolins,M.Z.,Wactawski- Wende, J., Wallace, R.B., Wassertheil-Smoller, S., Whitlock, E., Yano, K., Adans-Campbell, L., Anderson, G. L., Assaf, A.R., Beresford, S.A.A., Black, H.R., Brunner, R. L., Brzyski, R.G., Ford, L., Gass, M., Hays, J., Heber, D., Heiss, G., Hendrix, S. L., Hsai, J., Hubbell, F.A., Jackson, R.D., Johnson, K.C., Kotchen, J.M., LaCroix, A. Z., Lane, D. S., Langer, R.D., Lasser, N. L. & Henderson, M.M. (2006) Low-fat dietary pattern and risk of invasive breast cancer. JAMA, 295, 629-642.
69. Riserus, U., Arner, P., Brismar, K. & Vessby, B. (2002a) Treatment with dietary trans-10 cis-12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care, 25, 1516-1521.
70. Riserus, U., Basu, S., Jovinge, S., Fredrikson, G.N., Arnlov, J. & Vessby, B. (2002b) Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein. Circulation, 106, 1925-1929.
71. Riserus, U., Vessby, B., Arnlov, J. & Basu, S. (2004) Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. American Journal of Clinical Nutrition, 80, 279-283.
72. Roche, H.M., Noone, E., Nugent, A. & Gibney, M. J. (2001) Conjugated linoleic acid: a novel therapeutic nutrient? Nutrition Research Reviews, 14, 173-187.
73. Roche, H.M., Noone, E., Sewter, C., Mc Bennett, S., Savage, D., Gibney, M. J., O'Rahilly, S. & Vidal-Puig, A. J. (2002) Isomer-dependent metabolic effects of conjugated linoleic acid. Diabetes, 51, 2037-2044.
74. Rombaut, R. & Dewettinck, K. (2006) Properties, analysis and purification of milk polar lipids. International Dairy Journal, 16, 1362-1373.
75. de Roos, B., Rucklidge, G., Reid, M., Ross, K., Duncan, G., Navarro, M.A., Arbones-Mainar, J.M., Guzman-Garcia, M.A., Osada, J., Browne, J., Loscher, C. E. & Roche, H.M. (2005) Divergent mechanisms of cis-9, trans-11- and trans-10, cis-12-conjugated linoleic acid affecting insulin resistance and inflammation in apoprotein E knockout mice: a proteomics approach. FASEB Journal, 19, 1746-1748.
76. Rueda, R., Maldonado, J., Narbona, E. & Gil, A. (1998) Neonatal dietary gangliosides. Early Human Development, 53, S135-S147.
77. Schmelz, E.M. (2004) Sphingolipids in the chemoprevention of colon cancer. Fronteers in Bioscience, 9, 2632-2639.
78. Schmelz, E.M., Mottillo, E. P., Baxa, A.C., Doyon-Reale, N. & Roberts, P. C. (2006) Effect of sphingosine and enigmol on mouse ovarian surface epithelial cells representing early, intermediate, and late stages of ovarian cancer. Journal of Nutrition, 135, 3045S.
79. Scimeca, J.A. (1999) Cancer inhibition in animals. Advances in Conjugated Linoleic Acid Research, Volume 1, (eds. M. P. Yurawecz, M.M. Mossoba, J.K.G. Kramer, M.W. Pariza & G. J. Nelson), pp. 420-443, AOCS Press, Champaign
80. Simopoulos, A. P. (2002) Omega-3 fatty acids in inflammation and autoimmune diseases. Journal of the American College of Nutrition, 21, 495-505.
81. Sniderman, A.D., Furberg, C.D., Keech, A., Roeters van Lennep, J. E., Frohlich, J., Jungner, J. & Walldius, G. (2003) Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet, 361, 777-780.
82. Sprong, R.C., Hulstein, M. F. & van der Meer, R. (2001) Bactericidal activities of milk lipids. Antimicrobial Agents Chemotherapy, 45, 1298-1301.
83. Sjogren, P., Rosell, M., Skoglund-Andersson, C., Zdravkovic, S., Vessby, B., de Faire, U., Hamsten, A., Hellenius, M-L. & Fisher, R.M. (2004) Milk-derived fatty acids are associated with a more favourable LDL particle size distribution in healthy men. Journal of Nutrition, 134, 1729-1735.
84. Toomey, S., Harhen, B., Roche, H.M., Fitzgerald, D. & Belton, O. (2006) Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis, 187, 40-49.
85. Terpstra, A.H.M. (2004) Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature. American Journal of Clinical Nutrition, 79, 352-361.
86. Tricon, S., Burdge, G.C., Kew, S., Banerjee, T., Russell, J. J., Jones, E. L., Grimble, R. F., Williams, C.M., Yaqoob, P. & Calder, P. C. (2004) Opposing effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on blood lipids in healthy humans. American Journal of Clinical Nutrition, 80, 614-620.
87. Valeille,K., Ferezou, J.,Amsier,G.,Quignard-Boulange,A., Parquet,M.,Gripois,D.,Dorovska-Taran, V. & Martin, J.-C. (2005) A cis-9, trans-11-conjugated linoleic acid-rich oil reduces the outcome of atherogenic process in hyperlipidemic hamster. American Journal of Physiology, 289, H652-H659.
88. Wahle, K.W. J., Heys, S.D. & Rotondo, D. (2004) Conjugated linoleic acids: are they beneficial or detrimental to health? Progress in Lipid Research, 43, 553-587.
89. Watkins, B.A., Shen, C.-L.,McMurtry, J. P., Xu, H., Bain, S.D., Allen, K.G.D. and Seifert,M. F. (1997) Dietary lipidsmodulate bone prostaglandin E2 production, insulin-like growth factor-1 concentration and formation rate in chicks. Journal of Nutrition, 127, 1084-1091.
90. Willett, W.C. (2001) Diet and cancer: one view at the start of the millennium. Cancer epidemiology. Biomarkers and Prevention, 10, 3-8.
91. Willett,W. C. (2002) Dietary fat is not a major determinant of body fat. American Journal of Medicine, 113, 47S-59S.
92. Wongtangtintharn, S., Oku, H., Iwasaki, H. & Toda, T. (2004) Effect of branched-chain fatty acid biosynthesis of human breast cancer cells. Journal of Nutritional Science and Vitaminology, 50, 137-143
93. Wright, K.C., Yang, P., Van Pelt, C. S., Hicks, M. E., Collin, P. & Newman, R.A. (2005) Evaluation of targeted arterial delivery of the branched chain fatty acid 12-methyltetradecanoic acid as a novel therapy for solid tumors. Journal of Experimental Therapeutics and Oncology, 5, 55-68.
94. Yanagi, S., Yamashita, M. & Imai, S. (1993) Sodium butyrate inhibits the enhancing effect of high fat diet on mammary tumorigenesis. Oncology, 50, 201-204.
95. Yang, Z., Liu, S., Chen, X., Chen, H., Huang, M. & Zheng, J. (2000) Induction of apoptotic cell death and in vivo growth inhibition of human cancer cells by a saturated branched-chain fatty, 13-methyltetradecanoic acid. Cancer Research, 60, 505-509.
96. Yu, Y., Correll, P.H. & van den Heuvel, J. P. (2002) Conjugated linoleic acid decreases the production of pro-inflammatory products in macrophages: evidence for a PPARa-dependent mechanism. Biochimica et Biophysica Acta, 1581, 89-99.
97. Zapolska-Downar, D., Siennicka, A., Kaczmarczyk, M., Zolodziej, B. & Naruszewicz, M. (2004) Butyrate inhibits cytokine-induced VCAM-1 and ICAM-1 expression in cultured endothelial cells: theroleofNF-kB and PPARa. Journal of Nutritional Biochemistry, 15, 220-228.
98. Zhu, W. & Smart, E. J. (2005) Myristic acid stimulates endothelial nitric-oxide synthase in a CD36- and AMP kinase-dependent manner. Journal of Biological Chemistry, 280, 29543-29550.
99. Zomer, A.W.M., van der Burg, B., Jansen, G.A., Wanders, R. J.A., Poll-The, B. T. & van der Saag, P. T. (2000) Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor a. Journal of Lipid Research, 41, 1801-1807.